The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
the Traverse trial is coming out in June of this year will be coming out the Endo meeting uh about cardiovascular but that was very similar the impetus part of the Traverse was hey we have no large trial in men we the Traverse 6 000 patients randomized placebo-controlled trial largest of its kind will be coming out pretty soon
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.